PCRP Transformative Impact Award

Objecte

All applications are expected to address at least one of the following areas:

i.Biomarker Development: Validation and qualification of biomarkers for early detection of clinically relevant disease or for prognosis or prediction and assessment of response to therapies

ii.Genetics: Understanding host or tumor genetics and epigenetics responsible for susceptibility, disease progression, and treatment outcomes for clinically relevant prostate cancer

iii.Imaging: Development of new anatomic, functional, and molecular imaging approaches for the detection and management of clinically relevant prostate cancer

iv.Mechanisms of Resistance: Understanding primary and acquired resistance to therapy

v.Survivorship and Palliative Care: Improving the quality of life and well-being of prostate cancer patients and their families

vi.Therapy: Identification of new targets, pathways, and therapeutic modalities

vii.Tumor and Microenvironment Biology: Understanding the intrinsic and extrinsic mechanisms contributing to tumor development and the progression of prostate cancer

 

Termini IISPV

Cal comunicar abans del 30 de maig 2013 que es vol participar a la convocatòria, enviant un e-mail a europa@iispv.cat . Termini: 06 de juny de 2013

Termini Oficial

Pre-application (Preproposal): June 19, 2013 5:00 p.m. Eastern Time

Application: October 2, 2013 11:59 p.m. Eastern Time

Estàs interessat?

Omple el següent formulari per rebre més informació: